Tech & Pharma
MasterCard has launched a new innovation R&D center in Singapore to research into new payment solutions.
Takeda has initiated enrollment of patients in Japan for the two ongoing global Phase III clinical trials for its anti-prostate cancer investigational agent, orteronel (TAK-700).
Watson Pharmaceuticals, Inc. has acquired generics pharmaceutical maker Ascent Pharmahealth for AU$375 million.
GE Global Research and A*STAR have signed an agreement to develop clinical cancer imaging technologies and diagnostics.
China has approved the world’s first hepatitis E virus (HEV) vaccine this month, said China’s Ministry of Science and Technology.
Amerigen Pharmaceuticals Limited has signed MOUs with two companies involved in the development of generic medicine in China.
Centrally located office in Singapore is set to be the launching pad for significant BIOTRONIK business development in the Asia Pacific region.
Chinese biopharmaceutical company Sinovac Biotech Ltd. has begun the Phase III clinical trial for its proprietary inactivated EV71 vaccine against hand, foot and mouth disease (HFMD).
Researchers are studying whether the pharmaceutical drug Sativex – registered for pain relief in multiple sclerosis patients – can help people better manage cannabis withdrawal symptoms as well.
SFJ Pharma Ltd. will conduct a Phase III clinical trial in Asia of Pfizer’s axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma following nephrectomy.